Similar articles

• Uridine diphosphate reductase of Ehrlich ascites tumor is insensitive to hydroxyurea.

  Murayama J, Morita T, Fukui N, Moriyama Y, Fujimura S. Murayama J, et al. Biochem Biophys Res Commun. 1985 Feb 15;126(3):1104-8. doi: 10.1016/0006-291x(85)90299-2. Biochem Biophys Res Commun. 1985. PMID: 3884001
• Altered ribonucleotide reductase activity in drug-resistant mammalian cells detected by an assay procedure for intact cells.

  Koropatnick SE, Wright JA. Koropatnick SE, et al. Enzyme. 1980;25(4):220-7. doi: 10.1159/000459256. Enzyme. 1980. PMID: 6998699
• Characterization of hydroxyurea (HYU) resistant S49 T lymphoma cells.

  Albert DA, Gudas LJ. Albert DA, et al. Adv Exp Med Biol. 1986;195 Pt B:305-9. doi: 10.1007/978-1-4684-1248-2_48. Adv Exp Med Biol. 1986. PMID: 3020910 No abstract available.
• The inhibition of ribonucleoside diphosphate reductase by hydroxyurea, guanazole and pyrazoloimidazole (IMPY).

  Moore EC, Hurlbert RB. Moore EC, et al. Pharmacol Ther. 1985;27(2):167-96. doi: 10.1016/0163-7258(85)90068-3. Pharmacol Ther. 1985. PMID: 3898152 Review. No abstract available.
• Nature and properties of mammalian ribonucleoside diphosphate reductase.

  Nutter LM, Cheng YC. Nutter LM, et al. Pharmacol Ther. 1984;26(2):191-207. doi: 10.1016/0163-7258(84)90016-0. Pharmacol Ther. 1984. PMID: 6398448 Review. No abstract available.